当前位置: 首页  > 股票分析 > 港股分析

CMS Strategy Weekly (14 Sep 2020) - China TSF beat; UK may break law in new Brex

2020/9/15 6:10:43 来源:招商证券 作者: 人评论

作者:Jessie GUO,Edith Qian,Harrington ZHANG时光:2020年09月14日重要性:普通报告行业评级:公司评级:相干股票代码:浏览权限: 该文章钻石卡、金卡、银卡客户可浏览全文摘要:Report title:CMS Strategy Weekly (14 Sep 2020) - China TSF beat; UK may break law…

作者: Jessie GUO,Edith Qian,Harrington ZHANG
时光: 2020年09月14日
重要性: 普通报告
行业评级:
公司评级:
相干股票代码:
浏览权限:   该文章钻石卡、金卡、银卡客户可浏览全文
摘要: Report title:CMS Strategy Weekly (14 Sep 2020) - China TSF beat; UK may break law in new Brexit turmoil
Analyst:Jessie GUO,Edith Qian,Harrington ZHANG
Report type:Strategy
Date:20200914
[Summary]

■ China August TSF beat expectations, as local govt bond issuance surged
■ ECB left all policy settings unchanged, without signalling alarm on Euro
■ Brexit trade talk is under threat due to UK’s new legislation proposal

What’s new. 1) COVID-19 outbreak: In Europe, the second wave continued to deteriorate. Average daily new cases over the past week reached c.8,000 and c.9,600 respectively in France and Spain, up 20% and 13% compared to the week before. Average daily new cases surged in the UK, up 67% w-o-w to c.3,000. 2) On September 10, the ECB held its policy meeting at which the Governing Council decided to leave all policy settings unchanged. In the post-meeting press conference, ECB President Lagarde revealed that the Council currently has no plan and did not even discuss the possibility of extending its PEPP programme. Meanwhile, President Lagarde also hinted that the Council is not particularly concerned about the recent rally of the euro, as it does not target exchange rate, but it is closely monitoring the potential impact on domestic inflation in the eurozone. 3) The UK government proposed a new legislation last week, which could override key parts of the Brexit Withdrawal Agreement that it reached with EU last year. The proposed Internal Market Bill is expected to “eliminate the legal force of parts of the withdrawal agreement” which include areas of state aid and Northern Ireland customs. Whether such a move is intended for negotiating purpose from the Johnson Ministry or for solving some of the “flaws” in the withdrawal agreement remains to be seen. The bill has drawn staunch criticism from both the EU and some UK politicians. The EU has warned that if the Bill were to be adopted, it would constitute an extremely serious violation of the Withdrawal Agreement and of international law, and called on the UK government to withdraw these measures from the draft Bill in the shortest time possible.

Macro data update. China: 1) August CPI grew 2.4% yoy, in line with consensus (July: 2.7%); August PPI declined 2.0% yoy, in line with consensus (July: -2.4%). 2) August M2 rose 10.4% yoy, missing consensus (July: 10.7%); August new Renminbi loans issued were RMB1,280bn, beating consensus (July: RMB992.7bn); August total social financing was RMB3,580bn, beating consensus (July: RMB1,690bn). US: 1) August CPI rose 1.3% yoy, beating consensus (July: 1.0%); August core PPI increased 0.6% yoy, far above consensus (July: 0.3%). 2) Initial claims for week ended September 5 were 884,000, missing forecasts (previous week: 884,000).

Stock markets. HSI/MXCN/CSI300 dropped by 0.8%/2.6%/3.0% over the past week. MXCN: Insurance (+0.6%) and Banks (+0.1%) outperformed while IT (-5.7%) and Diversified Financials (-4.8%) lagged. A shares: Insurance (+3.1%) outperformed while Health Care (-6.2%) and IT (-6.1%) lagged. HSI/MXCN/CSI300 trade at forward P/E of 11.6x/15.5x/14.4x respectively (vs. 3-yr median of 11.2x/12.4x/12.5x). We have projected HSI to stay trend-ranged since April; expect a better performance in 4Q; expect MSCI China Index and CSI 300 to continue outperform major markets. Key catalysts/risks: 1) macro data; 2) COVID-19 infection development; 3) Sino-US relationship.

[投资评级界说]

公司短期评级

以报告日起6个月内,公司股价相对同期市场基准(沪深300指数)的表示为尺度:激烈引荐:公司股价涨幅超基准指数20%以上
谨慎引荐:公司股价涨幅超基准指数5-20%之间
中性:公司股价更改幅度相对基准指数介于±5%之间
回避:公司股价表示弱于基准指数5%以上

公司长期评级
A:公司长期竞争力高于行业均匀程度
B:公司长期竞争力与行业均匀程度分歧
C:公司长期竞争力低于行业均匀程度

[重要声明]
报告中的内容和看法仅供参考,并不组成对所述证券买卖的出价,在任何情形下,本报告中的信息或所表述的看法并不组成对任何人的投资建议。

相关资讯

    暂无相关的数据...

共有条评论 网友评论

验证码: 看不清楚?